Bionano Genomics (BNGO)

• Market cap: $8.43M
• 1 day: 1.12%
• 5 days: -63.41%
• 1 month: -42.86%
• 3 months: -44.79%
• 6 months: -48.13%
• Year to date: -88.25%
• 1 year: -92.86%
• 5 years: -99.52%
• 10 years: -99.96%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Employees: 100

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

11% more capital invested

Capital invested by funds: $291K [Q1] → $321K (+$30.6K) [Q2]

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

0.67% less ownership

Funds ownership: 3.81% [Q1] → 3.15% (-0.67%) [Q2]

3% less funds holding

Funds holding: 29 [Q1] → 28 (-1) [Q2]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $11
• Avg. target: $11
• High target: $11

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

HC Wainwright & Co. Yi Chen

$11

Buy Maintained

18 Aug 2025